Teva Investigational Site 220 is a clinical research site located in Kirkland, Washington, United States 98034.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Teva Investigational Site 220 has participated in 2 clinical trials.
Therapeutic areas: Chorea Associated With Huntington Disease, Chorea.
Sponsors: Auspex Pharmaceuticals, Inc., Teva Branded Pharmaceutical Products R&D, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Washington · View every site in Kirkland
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Teva Investigational Site 220 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Teva Investigational Site 220 has 2 clinical trials on record. Their work covers Chorea Associated With Huntington Disease, Chorea.
Teva Investigational Site 220 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.